Research Topics
| P WoodardSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndromePaul Woodard
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Pediatr Blood Cancer 47:931-5. 2006..Therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) carry a poor prognosis. We analyzed the results of allogeneic HSCT in 38 children to determine which factors, if any, affected outcome...
Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosisP Woodard
Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Bone Marrow Transplant 33:1151-7. 2004..However, a standardized approach to accurate and timely diagnosis and treatment is needed to improve outcome in these patients...
Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemiaP Woodard
Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Bone Marrow Transplant 33:411-8. 2004..Further study is required to validate the initial promise of these preliminary observations...
New approaches to hematopoietic cell transplantation for hematological diseases in childrenPaul Woodard
Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, TN, 38105, USA
Pediatr Clin North Am 49:989-1007. 2002..This would serve to provide potentially more children who could benefit from stem cell transplantation with donors. These advances will hopefully lead to benefits for the majority of children who lack HLA-identical donors...
Summary of symposium: the future of stem cell transplantation for sickle cell diseasePaul Woodard
Division of Stem Cell Transplantation, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA
J Pediatr Hematol Oncol 24:512-4. 2002
Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell diseasePaul Woodard
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 N Lauderdale Street, Lauderdale, Memphis, TN 38105, USA
Br J Haematol 129:550-2. 2005..Transient changes occurred early in two patients. Persistent changes occurred in five. Parenchymal lesions occurred in zero of two patients without prior lacunae or infarcts and in all seven with prior lacunae or infarcts (P = 0.0278)...
Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipientsPaul Woodard
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
J Pediatr Hematol Oncol 25:955-9. 2003..To determine the incidence, etiology and outcome of graft failure in pediatric allogeneic bone marrow transplant (BMT) recipients...
Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaP Woodard
Division of Bone Marrow Transplantation, Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
Bone Marrow Transplant 27:589-92. 2001..T cell-depleted MUD BMT is an effective treatment option for PNH-related MDS and SAA...
Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndromeW Leung
The Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA
Bone Marrow Transplant 27:717-22. 2001..Immune function 1 year after transplantation and the incidences and spectra of late sequelae were similar for both groups during a median of 3.5 years (range, 1.5 to 7.2 years) of follow-up...
Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donorsW H Leung
Department of Hematology Oncology, Laboratory Medicine and Pathology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Hum Immunol 62:399-407. 2001..Results of this study suggest that disparity in HLA-A and HLA-B antigens may not be better tolerated than disparity in HLA-DR allele in allogeneic BMT. Further studies are warranted to confirm our results...
A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTsX Chen
Department of Oncology, Division of Bone Marrow Transplantation and Cellular Therapy, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Bone Marrow Transplant 43:525-32. 2009..Stem cell mobilization caused a transient increase of KIR expression. We conclude that KIR expression differs quantitatively with age and primary disease and is transiently altered by stem cell recruitment and selection...
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcomeG A Hale
Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude s Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Biol Blood Marrow Transplant 9:698-705. 2003..032), or antithymocyte globulin (P =.0446). Multiple regression analysis revealed male sex (beta =.97; P =.027) and unrelated donor graft recipients (beta =.83; P =.039) to be significant factors...
Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantationSandra K Call
Department of Pharmaceutical Services, St Jude Children s Research Hospital, Memphis, Tennessee 38105 3678, USA
Biol Blood Marrow Transplant 15:274-8. 2009..These conclusions may not apply to patients with nonmalignant disorders...
Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002Kimberly A Kasow
Division of Bone Marrow Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Biol Blood Marrow Transplant 13:831-7. 2007....
Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patientsUsman Yusuf
Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Transplantation 81:1398-404. 2006..We report our experience with cidofovir (CDV) for treatment of ADV infection in 57 HSCT patients, median age 8 years (range 0.5-26)...
EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantationKimberly A Kasow
Department of Hematology Oncology, Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Pediatr Blood Cancer 49:869-72. 2007..She subsequently developed disseminated PTLPD involving multiple organ and nodal sites. Her neoplastic lymphoblasts were host-derived and refractory to rituximab treatment due to lack of CD20 expression...
Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experienceKimberly A Kasow
Division of Bone Marrow Transplantation and Cellular Therapy, Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Biol Blood Marrow Transplant 15:490-5. 2009..The decision to perform chest CT should be made judiciously based on a careful history and physical examination. Sinus imaging, which was frequently abnormal, may be justified in all patients to plan post-HSCT care...
Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemiaTerrence L Geiger
Department of Pathology, Mail Stop 341, St Jude Children s Research Hospital, 132 North Lauderdale Street, Memphis, TN 38105 2794, USA
Br J Haematol 117:634-41. 2002..Identifying the mechanism for the increased alloimmunization risk may assist in the development of therapies to prevent platelet refractoriness...
T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantationEric J Lowe
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN, USA
Br J Haematol 123:323-6. 2003..In contrast, donor T-cell incompatibility was a risk factor for acute GVHD, chronic GVHD and death. Thus, T-cell alloreactivity dominated that of NK cells in minimally T-cell-depleted grafts...
Diagnostic challenge in recurrent skin rash after autologous bone marrow transplantationHiroto Inaba
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
J Pediatr Hematol Oncol 28:525-8. 2006..Establishment of diagnostic criteria and understanding of the pathophysiology of these entities may lead to better management and to improved therapy of refractory cancer...
Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignanciesXiaohua Chen
Division of Bone Marrow Transplantation, St Jude Children's Research Hospital, Memphis, TN, USA
Br J Haematol 135:524-32. 2006..Rapid T-cell reconstitution, retention of NK-cells in the graft and induction of low grade GvHD may also enhance the potential anti-cancer immune effect...
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell diseaseFranco Locatelli
Oncoematologia Pediatrica, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Policlinico San Matteo, Universita di Pavia, Italy
Blood 101:2137-43. 2003..Related CBT for hemoglobinopathies offers a good probability of success and is associated with a low risk of GVHD. Optimization of transplantation strategies could further improve these results...
Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndromeSatkiran S Grewal
Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
Genet Med 7:143-6. 2005..Development of antibodies against exogenous enzyme does not appear to correlate with infusion reactions or response to ERT. A prospective study is needed to determine the effect of concomitant ERT on transplant outcomes...
Re: measurement of chimerism after hematopoietic stem cell transplantationPaul Woodard
Biol Blood Marrow Transplant 8:170. 2002
Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilationRobert F Tamburro
Penn State Children s Hospital, Pennsylvania State University College of Medicine, Milton S Hersey Medical Center, Hersey, PA, USA
Pediatr Crit Care Med 9:270-7. 2008....
Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosisH Evin Gulbahce
Department of Laboratory Medicine and Pathology, University of Minnesota, Fairview University Medical Center, Minneapolis 55455, USA
Am J Clin Pathol 121:205-10. 2004..Histologic examination is accurate in determining the cause of PNLs and identifying lesions that have a favorable outcome and those that require a change in treatment...
